Sionna Therapeutics, Inc.
NASDAQ:SIONBiotechnology
Healthcare
$2.97 +1.85%
+$0.68 today
- Market cap
- $134.35M
- Beta
- 1.29
- P/E (TTM)
- -19.7
- EPS (TTM)
- -$1.90
52W Low $13.81High $48.45
Volume 0.65M
Average 0.39M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$88.98M
FY 2025 · Annual
Net Income
-$75.27M
FY 2025 · Annual
Income Statement
USD
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 668K | 647K |
| Gross Profit | 0 | 0 | (668K) | (647K) |
| Gross Margin | — | — | — | — |
| Research & Development | 34.61M | 40.63M | 57.29M | 60.26M |
| Selling, General & Admin | 6.77M | 9.71M | 13.27M | 28.72M |
| Operating Expenses | 41.37M | 50.33M | 69.89M | 88.34M |
| Depreciation & Amortization | 122K | 583K | 668K | 647K |
| EBITDA | (40.12M) | (46.68M) | (61.02M) | (74.62M) |
| EBITDA Margin | — | — | — | — |
| Operating Income | (41.37M) | (50.33M) | (70.56M) | (88.98M) |
| Operating Margin | — | — | — | — |
| Interest Income | 1.13M | 2.77M | 8.17M | 13.3M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 1.13M | 3.07M | 8.87M | 13.71M |
| Income Before Tax | (40.24M) | (47.26M) | (61.69M) | (75.27M) |
| Pre-Tax Margin | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | (40.24M) | (47.26M) | (61.69M) | (75.27M) |
| Net Margin | — | — | — | — |
| EPS (Basic) | (0.91) | (1.07) | (1.40) | (1.88) |
| EPS (Diluted) | (0.91) | (1.07) | (1.40) | (1.88) |
| 44.12M | 44.12M | 44.12M | 39.96M | |
| 44.12M | 44.12M | 44.12M | 39.96M |
SION Earnings Waterfall · TTM
NASDAQ:SION · Revenue to Net Income
Key Ratios
EPS$-1.93
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-16.4
P/S Ratio0.0
Analysis
$0 of revenue converted into -$85.6M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.93, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| SC 13G | SC 13G filing | Nov 9, 2026 | |
| SC 13D/A | SC 13D/A filing | Sep 21, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 21, 2026 |
How much revenue does SION generate?
Sionna Therapeutics, Inc. (SION) reported $0.00 of revenue in fiscal 2025.
Is SION profitable?
Sionna Therapeutics, Inc. (SION) reported -$75.27M of net income.
Continue the stock analysis
Jump to another research area for this company.